• Acifran Workflows for HCAR2/HCAR3 Research

  2026-09-18

  Acifran enables controlled HCAR2/GPR109A and HCAR3/GPR109B agonism for cAMP, receptor pharmacology, and lipid metabolism workflows. Structure-guided pairing of receptor assays with careful compound handling helps distinguish ligand response from solubility, expression, and assay-window artifacts.

• Protein A/G Magnetic Co-IP/IP Kit for IVDD

  2026-09-18

  Learn how the Protein A/G Magnetic Co-IP/IP Kit can translate BATF2-ATF3 findings into rigorous protein-complex experiments in intervertebral disc degeneration. This guide connects magnetic immunoprecipitation design with mitochondrial biology, controls, workflow choices, and interpretation limits.

• LY2886721: From BACE1 Potency to Assay Design

  2026-09-17

  LY2886721 is a BACE inhibitor suited to mechanistic Alzheimer’s disease research. This article explains how to connect biochemical potency, APP-processing biomarkers, amyloid beta reduction, and synaptic readouts into a better experimental design.

• TCAIM–OGDH Control of Mitochondrial Metabolism

  2026-09-17

  The 2025 Molecular Cell study identifies TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and lowers its abundance through an HSPA9- and LONP1-dependent process. The findings establish mitochondrial proteostasis as an active regulator of metabolic enzyme levels, OGDH complex activity, and carbohydrate catabolism in cells and mice.

• Berberrubine chloride Research Workflows

  2026-09-16

  Build mechanism-led workflows around Berberrubine chloride for colorectal cancer, NSCLC chemosensitivity, hyperuricemia, and enzyme-mediated drug-interaction studies. The platform combines DMSO-compatible formulation, multi-target biology, and a newly defined mechanism-based CYP2D6 inactivation workflow.

• Ampicillin sodium for Selection and Assay Workflows

  2026-09-16

  Ampicillin sodium supports two complementary research needs: plasmid selection during recombinant protein production and controlled β-lactam exposure in antibacterial activity assays. This guide connects those use cases with a reference-based annexin V workflow, practical protocol parameters, and troubleshooting strategies for reproducible results.

• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-09-15

  FITC-Concanavalin A (ConA) Conjugate is a fluorescent lectin reagent for detecting α-D-glucose and α-D-mannose residues on glycoproteins and glycolipids in cell or tissue samples. It supports immunofluorescence staining and flow cytometry carbohydrate analysis, but it should not be treated as a general glycan stain, an antibody substitute, or a probe for non-carbohydrate targets.

• FLOT1–FOSL2–EphA2 Axis in AD Neuroinflammation

  2026-09-15

  A 2026 Neuropharmacology study identifies a FLOT1–FOSL2–EphA2 regulatory axis that promotes pro-inflammatory microglial polarization through p38/MAPK signaling in an APP/PS1 model. By combining molecular interaction assays with behavioral testing, the work connects a defined transcriptional mechanism to neuroinflammation and impaired spatial memory, while also clarifying how the pathway might be examined in complementary cell-based systems.

• BCA Protein Quantification Kit K4102 Guide

  2026-09-14

  The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 supports total-protein measurement in dilute samples, including many detergent-containing preparations and cell lysates. It is intended for scientific research workflows such as sample normalization and is not for diagnostic, clinical, or medical testing.

• BCA Protein Quantification Kit: K4102 Guide

  2026-09-14

  The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 supports sensitive total-protein measurement in dilute samples, including many detergent-containing preparations and cell lysates. It is intended for scientific research workflows such as sample normalization and is not validated for diagnostic, clinical, or medical use.

• Açaí Extracts in Human Hepatocytes: Key Findings

  2026-09-13

  Raichura and colleagues combined cytotoxicity testing, hepatocyte gene-expression analysis, and complementary transporter assays to evaluate whether consumer-relevant açaí extracts alter pharmacokinetic pathways. The study found extract-specific, dose- and time-dependent loss of hepatocyte viability but little evidence of CYP or transporter induction, supporting more disciplined evaluation of botanical–drug interaction risk.

• (R)-MG132: A Rigorous Proteasome Negative Control

  2026-09-12

  (R)-MG132 is an MG-132 enantiomer with markedly reduced 20S proteasome chymotrypsin-like inhibition. Its functionally inactive profile supports proteasome inhibition validation, cell-based assay proteasome control, and mechanistic studies that separate on-target effects from nonspecific toxicity.

• Potassium Iodide in Thyroid Assay Design

  2026-09-11

  Potassium Iodide (KI) gives researchers a defined iodide variable for thyroid uptake, hormone-synthesis, and radioactive iodine competition assays. This guide turns a soluble research reagent into a controlled workflow, then connects its assay-design logic with responsive delivery principles from combination immunotherapy.

• Partial BACE Inhibition and Synaptic Transmission

  2026-09-11

  Satir et al. examined whether moderate β-secretase inhibition can lower amyloid beta secretion without disrupting neuronal communication. Using primary rat cortical cultures, optical electrophysiology, and three BACE inhibitors, the study found that reductions below 50% were not associated with impaired synaptic transmission, whereas stronger inhibition decreased both amyloid beta secretion and synaptic activity.

• BIBR 1532: Telomerase Inhibitor Workflows

  2026-09-10

  BIBR 1532 gives oncology researchers a non-nucleosidic route to interrogate hTERT-dependent telomerase biology, connecting telomerase activity assays with proliferation and apoptosis readouts. This workflow guide shows how to pair short-term molecular measurements with longer-term telomere and cell-fate analyses while avoiding common solubility, timing, and normalization errors.

7963 records 1/531 page Next 12345 下5页 Last page